A detailed history of Gryphon Financial Partners LLC transactions in Cvs Health Corp stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 4,198 shares of CVS stock, worth $186,223. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,198
Previous 4,053 3.58%
Holding current value
$186,223
Previous $239,000 10.04%
% of portfolio
0.04%
Previous 0.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$55.81 - $63.18 $8,092 - $9,161
145 Added 3.58%
4,198 $263,000
Q2 2024

Aug 07, 2024

SELL
$53.63 - $79.56 $54,970 - $81,549
-1,025 Reduced 20.19%
4,053 $239,000
Q1 2024

May 01, 2024

SELL
$71.99 - $81.42 $221,225 - $250,203
-3,073 Reduced 37.7%
5,078 $405,000
Q4 2023

Feb 06, 2024

BUY
$66.29 - $79.0 $175,867 - $209,587
2,653 Added 48.25%
8,151 $643,000
Q3 2023

Nov 07, 2023

SELL
$65.17 - $76.41 $12,251 - $14,365
-188 Reduced 3.31%
5,498 $383,000
Q2 2023

Aug 08, 2023

SELL
$66.65 - $77.75 $36,524 - $42,607
-548 Reduced 8.79%
5,686 $393,000
Q1 2023

May 03, 2023

SELL
$72.37 - $92.89 $26,053 - $33,440
-360 Reduced 5.46%
6,234 $463,000
Q4 2022

Feb 08, 2023

SELL
$88.25 - $103.78 $93,809 - $110,318
-1,063 Reduced 13.88%
6,594 $614,000
Q3 2022

Nov 14, 2022

BUY
$92.53 - $106.43 $205,231 - $236,061
2,218 Added 40.78%
7,657 $730,000
Q2 2022

Jul 28, 2022

BUY
$88.66 - $106.64 $28,193 - $33,911
318 Added 6.21%
5,439 $504,000
Q1 2022

May 05, 2022

BUY
$100.77 - $110.83 $3,728 - $4,100
37 Added 0.73%
5,121 $518,000
Q4 2021

Feb 01, 2022

BUY
$83.15 - $103.7 $8,231 - $10,266
99 Added 1.99%
5,084 $525,000
Q3 2021

Nov 12, 2021

SELL
$80.05 - $87.47 $11,367 - $12,420
-142 Reduced 2.77%
4,985 $424,000
Q2 2021

Aug 13, 2021

SELL
$73.79 - $89.81 $147 - $179
-2 Reduced 0.04%
5,127 $381,000
Q1 2021

May 05, 2021

BUY
$68.13 - $76.3 $7,630 - $8,545
112 Added 2.23%
5,129 $386,000
Q4 2020

Feb 10, 2021

BUY
$55.93 - $74.5 $14,653 - $19,519
262 Added 5.51%
5,017 $343,000
Q3 2020

Nov 16, 2020

BUY
$56.71 - $65.71 $269,656 - $312,451
4,755 New
4,755 $278,000
Q2 2020

Aug 13, 2020

SELL
$55.41 - $70.62 $232,500 - $296,321
-4,196 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$52.3 - $76.05 $2,039 - $2,965
39 Added 0.94%
4,196 $249,000
Q4 2019

Feb 06, 2020

SELL
$60.38 - $76.58 $1,147 - $1,455
-19 Reduced 0.45%
4,157 $308,000
Q3 2019

Nov 07, 2019

BUY
$54.09 - $64.3 $225,879 - $268,516
4,176 New
4,176 $264,000
Q3 2018

Nov 06, 2018

SELL
$63.78 - $79.59 $31,315 - $39,078
-491 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$60.71 - $72.18 $6,313 - $7,506
104 Added 26.87%
491 $32,000
Q1 2018

May 14, 2018

SELL
$60.6 - $83.63 $8,968 - $12,377
-148 Reduced 27.66%
387 $24,000
Q4 2017

Feb 09, 2018

BUY
$66.8 - $80.91 $35,738 - $43,286
535
535 $39,000

Others Institutions Holding CVS

About CVS HEALTH Corp


  • Ticker CVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 1,312,829,952
  • Market Cap $58.2B
  • Description
  • CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...
More about CVS
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.